Search results
Results from the WOW.Com Content Network
However, the UK's chief medical officers agreed to the rollout of a single dose of the Pfizer vaccine to this age group on 13 September in order to reduce disruption to education. [106] Second doses, three months or more after their first, were expanded to this age range on 29 November. [107]
Among the over-80s, Covid testing data on more than 12,000 people found at least 57% protection against coronavirus 28 days after vaccination with a single dose of Pfizer, rising to 88% after a ...
The approval of the Pfizer-BioNTech vaccine was extended to young people aged 12–15 in June 2021, [31] 5–11 in December 2021, [32] and from six months in December 2022. [33] The status of the Oxford / AstraZeneca vaccine was upgraded to conditional marketing authorisation on 24 June 2021. [28]
The committee was established in 1963, having been until then an advisory board for polio immunisation. [1] It gained statutory status as the Standing Advisory Committee on Vaccination and Immunisation, a non-departmental public body [2] advising the Secretary of State for Social Services and the Secretary of State for Wales, under the National Health Service (Standing Advisory Committees ...
In total, the UK has ordered 40 million doses of the Pfizer-Biontech vaccine and 17 million of the Moderna vaccine, the two brands approved at the time (enough for up to 28.5 m people). [102] Several EU member states had also restricted the use of the AstraZeneca jab, in Germany to those over 60, in France to over 55s, and Spain to over 65s. [103]
One dose of Pfizer or Moderna vaccines appears at least 80% effective against symptomatic COVID-19. For AstraZeneca, one-shot efficacy is 70%.
The New York City Department of Health and Mental Hygiene tweeted an update on vaccine availability Thursday. ... is eligible for at least one dose of the updated Covid-19 vaccines; the shots are ...
Leaflets and other programme materials, early 2021. The Vaccine Taskforce in the United Kingdom of Great Britain and Northern Ireland was set up in April 2020 by the Second Johnson ministry, in collaboration with Chief Scientific Advisor Patrick Vallance and Chief Medical Officer Professor Chris Whitty, in order to facilitate the path towards the introduction of a COVID-19 vaccine in the UK ...